東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Cancer vaccines = from research to c...

Bot, Adrian.

FindBook

Google Book

Amazon

博客來

Cancer vaccines = from research to clinical practice /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Cancer vaccines/ edited by Adrian Bot, Mihail Obrocea, and Francesco Marincola.
其他題名:	from research to clinical practice /
其他作者:	Bot, Adrian.
出版者:	New York :Informa Healthcare, : 2011.,
面頁冊數:	xvi, 280 p. :ill.
內容註:	Vaccine platforms for genito-urinary cancers, with potential applicability to other tumors -- Vaccines for solid cancers and hematological malignancies -- Vaccine development : trial design and immune assays -- Emerging new vaccine strategies, targets, and adjuvants -- Next-generation hybrid active/passive immunotherapies.
標題:	Cancer vaccines. -
電子資源:	http://marc.crcnetbase.com/isbn/9781841848303Distributed by publisher. Purchase or institutional license may be required for access.
ISBN:	9781841848303 (ebook : PDF)

Cancer vaccines = from research to clinical practice /
Cancer vaccinesfrom research to clinical practice /[electronic resource] :edited by Adrian Bot, Mihail Obrocea, and Francesco Marincola. - New York :Informa Healthcare,2011. - xvi, 280 p. :ill.

Includes bibliographical references and index.

Vaccine platforms for genito-urinary cancers, with potential applicability to other tumors -- Vaccines for solid cancers and hematological malignancies -- Vaccine development : trial design and immune assays -- Emerging new vaccine strategies, targets, and adjuvants -- Next-generation hybrid active/passive immunotherapies.

"Recent advances in immunology and biology have opened new horizons in cancer therapy, included in the expanding array of cancer treatment options, which are immunotherapies, or cancer vaccines, for both solid and blood borne cancers. Cancer Vaccines: Challenges and Opportunities in Translation is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist. Cancer Vaccines: Challenges and Opportunities in Translation: critically analyzes the most promising classes of investigational immunotherapies, integrating their scientific rationale and clinical potential, discusses "theranostics" as pertaining to immunotherapy, i.e., using molecular diagnostics to identify patients that would most likely benefit from a therapy, presents the new paradigm of biomarker guided R&D and clinical development in immunotherapy of cancer and reviews bottlenecks in translational process of immunotherapies and offers strategies to resolve them"--Provided by publisher.

Mode of access: World Wide Web.

ISBN: 9781841848303 (ebook : PDF)Subjects--Topical Terms:

840697
Cancer vaccines.
Index Terms--Genre/Form:

542853
Electronic books.

Cancer vaccines = from research to clinical practice /
LDR:02357nmm 2200265Ia 4500 001 1987425
003 FlBoTFG
005 20130702144629.0
006 m|||||o||d||||||||
007 cr||||
008 150727s2011 nyuad sb 001 0 eng d
020 $a 9781841848303 (ebook : PDF)
035 $a CRC0HE10435PDF
040 $a FlBoTFG $c FlBoTFG
090 $a RC271.I45 $b C43 2011
092 $a 616.994061 $b C215
245 0 0 $a Cancer vaccines $h [electronic resource] : $b from research to clinical practice / $c edited by Adrian Bot, Mihail Obrocea, and Francesco Marincola.
260 $a New York : $b Informa Healthcare, $c 2011.
300 $a xvi, 280 p. : $b ill.
504 $a Includes bibliographical references and index.
505 0 $a Vaccine platforms for genito-urinary cancers, with potential applicability to other tumors -- Vaccines for solid cancers and hematological malignancies -- Vaccine development : trial design and immune assays -- Emerging new vaccine strategies, targets, and adjuvants -- Next-generation hybrid active/passive immunotherapies.
520 $a "Recent advances in immunology and biology have opened new horizons in cancer therapy, included in the expanding array of cancer treatment options, which are immunotherapies, or cancer vaccines, for both solid and blood borne cancers. Cancer Vaccines: Challenges and Opportunities in Translation is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist. Cancer Vaccines: Challenges and Opportunities in Translation: critically analyzes the most promising classes of investigational immunotherapies, integrating their scientific rationale and clinical potential, discusses "theranostics" as pertaining to immunotherapy, i.e., using molecular diagnostics to identify patients that would most likely benefit from a therapy, presents the new paradigm of biomarker guided R&D and clinical development in immunotherapy of cancer and reviews bottlenecks in translational process of immunotherapies and offers strategies to resolve them"--Provided by publisher.
530 $a Also available in print edition.
538 $a Mode of access: World Wide Web.
650 0 $a Cancer vaccines. $3 840697
655 7 $a Electronic books. $2 lcsh $3 542853
700 1 $a Bot, Adrian. $3 1359715
700 1 $a Obrocea, Mihail. $3 1359716
700 1 $a Marincola, Francesco M. $3 1531036
776 1 $z 9781841848297 (hardback : alk. paper)
856 4 0 $u http://marc.crcnetbase.com/isbn/9781841848303 $q application/PDF $z Distributed by publisher. Purchase or institutional license may be required for access.